EMEA-002566-PIP01-19

Key facts

Active substance
(R)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1H-imidazo[4,5-c]pyridin-2(3H)-one (SAR442168)
Therapeutic area
Neurology
Decision number
P/0310/2020
PIP number
EMEA-002566-PIP01-19
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of multiple sclerosis
Route(s) of administration
Oral use
Contact for public enquiries
Sanofi-Aventis Groupe

Email: contact-us@sanofi.com
Tel: +31 202 453 703

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating